Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
AssigneeThe Immune Response Corporation
InventorWilliam Soo Hoo
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Immune Response Corporation
InventorWilliam Soo Hoo
Estimating the term…
The present invention provides a cellular vaccine having a membrane-bound fusion protein that includes a non-antibody immunomodulatory molecule such as GM-CSF operatively fused to a heterologous membrane attachment domain. Non-antibody immunomodulatory molecules useful in the invention include immunostimulatory and immunosuppressive molecules such as cytokines. In one embodiment, the invention provides a cellular vaccine having a membrane-bound fusion protein that includes a non-antibody immunomodulatory molecule operatively fused to a heterologous membrane attachment domain and, additionally, a disease-associated antigen or immunogenic epitope thereof. Further provided by the invention are methods of modulating an immune response against a disease-associated antigen by administering to an individual a cellular vaccine having a membrane-bound fusion protein that includes a non-antibody immunomodulatory molecule operatively fused to a heterologous membrane attachment domain.
A pharmaceutical composition, comprising a cell having a membrane bound fusion protein comprising Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) fused to a heterologous membrane attachment domain, said cell further comprising a disease-associated antigen or immunogenic epitope thereof.
A method of stimulating an immune response against a disease-associated antigen, comprising administering to an individual a pharmaceutical composition comprising a cell having:
Dependencies are inferred from the claim text.